ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,623Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 351

$1.84M Total Retail Price of All Prescriptions

Rank: 2 out of 351

983 Patients Receiving at Least One Drug in Part D
97% Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Georgia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 983 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 17%. This is far more than peers.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $96 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Georgia
NAMENDA 1,683 1,628 257 1 33
EXELON 1,602 1,565 285 10 2 44
RISPERIDONE 1,152 1,102 203 A 3 3
VENLAFAXINE HCL ER 1,011 929 144 10 4 14
GABAPENTIN 963 897 184 5 23
QUETIAPINE FUMARATE 945 891 165 A 6 2
ESCITALOPRAM OXALATE 755 750* 155 7 18
SERTRALINE HCL 751 719 120 8 7
CLONAZEPAM 745 688 147 B 9 4
DONEPEZIL HCL 515 510* 107 10 35
OLANZAPINE 511 452 84 A 11 10
ABILIFY 383 346 67 A 12 16
MIRTAZAPINE 372 343 63 13 13
LORAZEPAM 329 300 129 B 14 21
METHYLPHENIDATE HCL 313 313 55 S2 15 55
OXCARBAZEPINE 306 301* 55 16 39
BUPROPION XL 294 289* 62 17 19
RIVASTIGMINE 275 275 38 10 18 83
LEVOTHYROXINE SODIUM 269 251 44 19 57
SEROQUEL XR 246 226 48 A 20 38
AMLODIPINE BESYLATE 196 196 31 21 68
LITHIUM CARBONATE 177 172* 34 22 28
OMEPRAZOLE 164 140 25 23 64
CITALOPRAM HBR 157 142 32 24 8
NAMENDA XR 146 146 44 25 113
SIMVASTATIN 137 113 19 26 75
PREMARIN 125 125 17 R 27 118
TRAMADOL HCL 122 122 31 28 74
VENLAFAXINE HCL 121 116* 19 29 51
METOPROLOL TARTRATE 106 101* 15 30 73
TAMSULOSIN HCL 102 102 17 31 106
BUPROPION HCL SR 92 87* 15 32 24
CYMBALTA 91 86* 13 33 15
PRAVASTATIN SODIUM 89 89 13 34 129
ALPRAZOLAM 87 70 20 B 35 5
TRAZODONE HCL 82 77* 22 36 1
FUROSEMIDE 77 77 17 37 96
FINASTERIDE 77 <11 <11 37 108
RANITIDINE HCL 75 70* 11 39 85
CLOMIPRAMINE HCL 73 55 13 R 40 98
ZOLPIDEM TARTRATE 72 <11 <11 41 11
PANTOPRAZOLE SODIUM 68 68 13 42 93
ATORVASTATIN CALCIUM 66 61* 18 43 143
LISINOPRIL 66 61* 14 43 60
LAMOTRIGINE 64 40 12 45 12
DIVALPROEX SODIUM 64 48 16 45 29
ZIPRASIDONE HCL 56 44 11 A 47 20
POTASSIUM CHLORIDE 54 <11 <11 48 115
METFORMIN HCL 53 <11 <11 49 86
CIPROFLOXACIN HCL 52 52 44 50 162
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.